申请人:BANYU PHARMA CO LTD
公开号:WO2010084979A1
公开(公告)日:2010-07-29
The present invention relates to a compound represented by the formula(I):wherein R1 represents a hydrogen atom or the like;R2 represents lower alkyl or the like;R3 and R4 represent lower alkyl or the like;R5 represents phenyl or the like;R6 represents a hydrogen atom or the like;m is an integer of from 0 to 2;p is an integer of from 1 to 4; and q is an integer of from 1 to 5, or a pharmaceutical acceptable saltthereof, and a DGAT 1 inhibitor comprising the compound.
本发明涉及一种由下式(I)表示的化合物:其中R1代表氢原子或类似物;R2代表较低的烷基或类似物;R3和R4代表较低的烷基或类似物;R5代表苯基或类似物;R6代表氢原子或类似物;m为0至2的整数;p为1至4的整数;q为1至5的整数,或其药用可接受盐,以及包括该化合物的DGAT 1抑制剂。